文献速递肿瘤 PET/CT

基于最大肿瘤播散距离与代谢肿瘤负荷的儿童非霍奇金淋巴瘤风险分层

Risk Stratification in Pediatric Non-Hodgkin Lymphoma Using Maximum Tumor Dissemination and Metabolic Tumor Burden on Baseline 18 F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2026-06-17

本研究回顾性纳入98例儿童非霍奇金淋巴瘤患者,评估基线18F-FDG PET/CT参数最大病灶间距离(Dmax)和总代谢肿瘤体积(TMTV)的预后价值。基于替代指标sTMTV和sDmax将患者分为无风险、1个风险因素和2个风险因素三组,单因素分析显示sTMTV、sDmax及PET风险分组与无事件生存和总生存显著相关。

要点

  • sTMTV和sDmax是儿童NHL的显著预后生物标志物。
  • 两者联合可将患者分为无风险、1个和2个风险因素组。
  • PET风险分组与无事件生存和总生存均相关。

核心结论

  • 基于FDG PET/CT的sTMTV和sDmax是儿童NHL的显著预后生物标志物,联合可有效分层风险组。

研究设计与样本

  • TMTV以41%最大标准化摄取值阈值为定义,计算所有病灶对间距离以确定Dmax。
  • 使用单因素分析评估FDG PET/CT参数及临床因素对生存结局的预后意义。

主要发现

  • 基于sTMTV和sDmax将患者分为无风险组(n=61)、1个风险因素组(n=17)和2个风险因素组(n=20)。
  • 单因素分析中,晚期(≥IV期)、骨髓受累、血清乳酸脱氢酶(LDH)升高(>500 IU/L)、sTMTV、sDmax及PET风险分组为无事件生存的显著预后因素(P<0.05)。
  • 对于总生存,显著因素包括LDH水平、sTMTV、sDmax及PET风险分组(P<0.05)。
  • PET风险分层也反映在生存结局中。

关键数值与推荐

  • TMTV定义采用41%最大标准化摄取值阈值。
  • LDH升高定义为>500 IU/L。
  • 晚期定义为≥IV期。

临床怎么用

  • 基线FDG PET/CT的sTMTV和sDmax可用于儿童NHL风险分层,辅助未来风险适应管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pediatric non-Hodgkin lymphoma (NHL) is the third most common childhood malignancy, but reliable prognostication remains challenging. This study aimed to evaluate the prognostic value of baseline 18 F-FDG PET/CT parameters reflecting disease spread, the largest interlesion distance (Dmax), and total metabolic tumor volume (TMTV), in pediatric patients with NHL. PATIENTS AND METHODS: We retrospectively enrolled 98 pediatric patients with NHL (74 males, 24 females; median age, 10.4 y; range, 0.3-17.9 y) who underwent FDG PET/CT for staging between January 2008 and November 2024. TMTVs were defined using a 41% maximum standardized uptake value threshold. Distances between all lesion pairs were calculated to determine Dmax. Prognostic significance of FDG PET/CT parameters and clinical factors for survival outcomes was evaluated using univariate analysis. RESULTS: Based on surrogate TMTV (sTMTV) and sDmax, patients were stratified into no (n = 61), 1-risk (n = 17), and 2-risk factor groups (n = 20). In the univariate analysis, advanced stage (≥IV), bone marrow involvement, elevated serum lactate dehydrogenase (LDH) level (>500 IU/L), sTMTV, sDmax, and the PET-based risk group were significant prognostic factors for event-free survival ( P < 0.05). For overall survival, significant factors included LDH level, sTMTV, sDmax, and the PET-based risk group ( P < 0.05). The PET-based risk stratification was also reflected in survival outcomes. CONCLUSIONS: sTMTV and sDmax derived from FDG PET/CT are significant prognostic biomarkers in pediatric NHL. Their combination enables effective stratification of pediatric patients with NHL into distinct risk groups and may inform future risk-adapted management strategies, potentially improving survival in this population.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Hwang SH, Ahn WK, Cho H, et al. Risk Stratification in Pediatric Non-Hodgkin Lymphoma Using Maximum Tumor Dissemination and Metabolic Tumor Burden on Baseline 18 F-FDG PET/CT. Clin Nucl Med. 2026. PMID: 42302721. doi:10.1097/RLU.0000000000006556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。